Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Prat

Showing results (221-230 of 268) with videos related to

Pageof 27
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 2025
Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosisYi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
The Journal of Clinical Investigation|February 26, 2021
Identification of SARS-CoV-2-specific immune alterations in acutely ill patientsRose-Marie Rébillard, Marc Charabati, Camille Grasmuck, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 7, 2017
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysisAlessio Signori, Guillermo Izquierdo, Alessandra Lugaresi, et al.
Cell Reports. Medicine|March 2, 2023
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4<sup>+</sup> T cell profileGérémy Sannier, Alexandre Nicolas, Mathieu Dubé, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024)Vilija G Jokubaitis, Raed Alroughani, Ayse Altintas, et al.
Science Advances|November 26, 2021
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortalityElsa Brunet-Ratnasingham, Sai Priya Anand, Pierre Gantner, et al.
Multiple Sclerosis and Related Disorders|January 10, 2019
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort studyAi-Lan Nguyen, Eva Kubala Havrdova, Dana Horakova, et al.
Cell|April 6, 2019
Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10Olga L Rojas, Anne-Katrin Pröbstel, Elisa A Porfilio, et al.
Cell|January 8, 2019
Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10Olga L Rojas, Anne-Katrin Pröbstel, Elisa A Porfilio, et al.
Brain : a Journal of Neurology|September 18, 2020
Delay from treatment start to full effect of immunotherapies for multiple sclerosisIzanne Roos, Emmanuelle Leray, Federico Frascoli, et al.
Pageof 27

Showing results (221-230 of 268) with videos related to

Sort By:
Pageof 27
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 2025
Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosisYi Chao Foong, Daniel Merlo, Melissa Gresle, et al.
The Journal of Clinical Investigation|February 26, 2021
Identification of SARS-CoV-2-specific immune alterations in acutely ill patientsRose-Marie Rébillard, Marc Charabati, Camille Grasmuck, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 7, 2017
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysisAlessio Signori, Guillermo Izquierdo, Alessandra Lugaresi, et al.
Cell Reports. Medicine|March 2, 2023
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4<sup>+</sup> T cell profileGérémy Sannier, Alexandre Nicolas, Mathieu Dubé, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women's Health Registry (2020-2024)Vilija G Jokubaitis, Raed Alroughani, Ayse Altintas, et al.
Science Advances|November 26, 2021
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortalityElsa Brunet-Ratnasingham, Sai Priya Anand, Pierre Gantner, et al.
Multiple Sclerosis and Related Disorders|January 10, 2019
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort studyAi-Lan Nguyen, Eva Kubala Havrdova, Dana Horakova, et al.
Cell|April 6, 2019
Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10Olga L Rojas, Anne-Katrin Pröbstel, Elisa A Porfilio, et al.
Cell|January 8, 2019
Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10Olga L Rojas, Anne-Katrin Pröbstel, Elisa A Porfilio, et al.
Brain : a Journal of Neurology|September 18, 2020
Delay from treatment start to full effect of immunotherapies for multiple sclerosisIzanne Roos, Emmanuelle Leray, Federico Frascoli, et al.
Pageof 27